These drugs, such as Enbrel, Stelara, Eliquis, Xarelto, Entresto, Imbruvica, Farxiga and many insulins, have list prices as ...

Johnson & Johnson has three of its top-selling drugs in Medicare pricing negotiations – Stelara, Xarelto, and Imbruvica – but has said it does not expect a major hit to its finances next year.

The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round of the Medicare negotiation programme by 1st February next year ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The role of ...

Drs Robert Glatter, Sergey Motov, and Gary Schwartz discuss a novel way to treat pain related to conditions such as rib ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 153,500 newsletter subscribers for 21 days.